G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes

BACKGROUND: Granzyme B is a key effector of cytotoxic T lymphocytes (CTLs), and its expression level positively correlates with the response of patients with mesothelioma to immune checkpoint inhibitor immunotherapy. Whether metabolic pathways regulate Gzmb expression in CTLs is incompletely underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Chunwan, Yang, Dafeng, Klement, John D, Colson, Yolonda L, Oberlies, Nicholas H, Pearce, Cedric J, Colby, Aaron H, Grinstaff, Mark W, Ding, Han-Fei, Shi, Huidong, Liu, Kebin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753452/
https://www.ncbi.nlm.nih.gov/pubmed/35017152
http://dx.doi.org/10.1136/jitc-2021-003543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753452/
https://www.ncbi.nlm.nih.gov/pubmed/35017152
http://dx.doi.org/10.1136/jitc-2021-003543

Ejemplares similares